Showing 1101-1110 of 1616 results for "".
- Azura Ophthalmics Announces Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunctionhttps://modernod.com/news/azura-ophthalmics-announces-positive-results-from-phase-2b-clinical-trial-of-azr-md-001-in-meibomian-gland-dysfunction/2481247/Azura Ophthalmics announced positive 3-month efficacy and safety results from its phase 2b study of AZR-MD-001 0.5% in Meibomian Gland Dysfunction (MGD). The trial met its co-primary endpoints of improvements in Meibomian Glands Yielding Liquid Secretion (MGYLS; number of open glands) and Oc
- Atsena Therapeutics Expands Leadership Team with Appointment of Lis Leiderman, MD, MBA, as Chief Financial Officer and Chief Business Officerhttps://modernod.com/news/atsena-therapeutics-expands-leadership-team-with-appointment-of-lis-leiderman-md-mba-as-chief-financial-officer-and-chief-business-officer/2481229/Atsena Therapeutics announced the appointment of Elisabeth (Lis) Leiderman, MD, MBA, as Chief Financial Officer and Chief Business Officer. Dr. Leiderman has more than 15 years of finance, business development and strategy experience in the life sciences industry, most recently with gene the
- Ophthalmologist Ashley Brissette, MD, Launches New Eye Area Skincare Line Daily Practicehttps://modernod.com/news/ophthalmologist-ashley-brissette-md-launches-new-eye-area-skincare-line-daily-practice/2480861/Daily Practice, a new eye care line by Ashley Brissette (Dr. B), MD, launched with a product called ‘Eye Revive.’ Having worked as an ophthalmologist for 6 years, New York City-based Dr. B said she recognized a growing trend of eye irritation, sensitivity and
- Ocuphire Appoints Jay Pepose, MD, PhD, as Chief Medical Advisor and Announces Upcoming Presentations at ASCRS 2022 and Eyeceleratorhttps://modernod.com/news/ocuphire-appoints-jay-pepose-md-phd-as-chief-medical-advisor-and-announces-upcoming-presentations-at-ascrs-2022-and-eyecelerator/2480777/Ocuphire Pharma announced the appointment of Jay Pepose, MD, PhD, as its Chief Medical Advisor. In addition, Dr. Pepose, Dr. Ralph Chu, and Dr. Marguerite McDonald will deliver three presentations on Nyxol at the American Society of Cataract and Refractive Surgery (ASCRS) which will
- 2022 President Robert E. Wiggins Jr., MD, MPH Takes the Academy’s Reinshttps://modernod.com/news/2022-president-robert-e-wiggins-jr-md-mph-takes-the-academys-reins/2480585/Medicine is a constantly developing industry—just ask 2022 Academy President Robert E. Wiggins Jr., MD, MPH. When his practice was acquired in the 1990s, Dr. Wiggins returned to school and obtained a masters degree in health care administration, turning Asheville Eye Associa
- Yehia Hashad, MD, to Join Bausch + Lomb as Executive Vice President of Research & Development and CMOhttps://modernod.com/news/yehia-hashad-md-will-join-bausch-lomb-as-executive-vice-president-of-research-development-and-cmo/2480581/Bausch Health Companies has announced that Yehia Hashad, MD, will join Bausch + Lomb as executive vice president of Research & Development and Chief Medical Officer (CMO), effective January 31, 2022. Dr. Hashad will join Bausch + Lomb from Allergan/AbbVie, where for the past 11
- Visus Therapeutics Appoints David Guyer, MD, as Chairman of the Board, and Names Ted Danse as Head of Business Developmenthttps://modernod.com/news/visus-therapeutics-appoints-david-guyer-md-as-chairman-of-the-board-and-names-ted-danse-as-head-of-business-development/2480395/Visus Therapeutics announced the appointment of ophthalmology and industry expert David Guyer, MD, as the chairman of the Board after serving as an advisor since the company’s inception, and life sciences veteran Ted Danse as the head of business development. “I&rs
- Kriya Therapeutics Appoints Theresa Heah, MD, as Chief Medical Officer and President of Kriya Ophthalmologyhttps://modernod.com/news/kriya-therapeutics-appoints-theresa-heah-md-as-chief-medical-officer-and-president-of-kriya-ophthalmology/2480354/Kriya Therapeutics announced the appointment of Theresa Heah, MD, MBA, as Chief Medical Officer and President of Kriya’s newly launched ophthalmology division, Kriya Ophthalmology. Dr Heah will be responsible for advancing Kriya’s current pipeline of ophthalmology gene therapies and c
- Aurion Biotech Appoints Professor Shigeru Kinoshita, MD, PhD, to Its Medical Advisory Boardhttps://modernod.com/news/aurion-biotech-appoints-professor-shigeru-kinoshita-md-phd-to-its-medical-advisory-board/2479369/Shigeru Kinoshita, MD, PhD, has joined the medical advisory board at Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases. Professor Kinoshita is the inventor of Aurion Biotech’s lead candidate, cell therapy for
- Ocuphire Announces Appointment of Jay S. Pepose, MD, PhD, to Its Board of Directorshttps://modernod.com/news/ocuphire-announces-appointment-of-jay-s-pepose-md-phd-to-its-board-of-directors/2479272/Ocuphire Pharma announced the appointment of Jay S. Pepose, MD, PhD, to its Board of Directors. Concurrent to Dr. Pepose’s appointment at Ocuphire’s annual shareholder meeting on June 7, Alan Meyer, MBA, retired from his role on the Board of Directors, having served since April 2018. “We a